Beh‡et's disease

被引:3
作者
Koetter, I. [1 ,8 ]
Xenitidis, T. [2 ,3 ]
Fierlbeck, G. [3 ,4 ]
Schanz, S. [3 ,4 ]
Melms, A. [5 ]
Horger, M. [6 ]
Ernemann, U. [6 ]
Deuter, C. [3 ,7 ]
机构
[1] Rheumatol Schwerpunktpraxis Stuttgart Bad Cannsta, Zentrum Interdisziplinare Rheumatol Stuttgart, D-70372 Stuttgart, Germany
[2] Univ Klinikum Tubingen UKT, Med Univ Klin Abt 2, Tubingen, Germany
[3] Univ Klinikum Tubingen UKT, INDIRA Interdisziplinares Zentrum Klin Immunol Rh, Tubingen, Germany
[4] Univ Klinikum Tubingen UKT, Univ Hautklin, Tubingen, Germany
[5] Univ Klinikum Tubingen UKT, Neurol Univ Klin, Tubingen, Germany
[6] Univ Klinikum Tubingen UKT, Radiol Univ Klin, Tubingen, Germany
[7] Univ Klinikum Tubingen UKT, Univ Augenklin, Tubingen, Germany
[8] Robert Bosch Krankenhaus, Abt Allgemeine Innere Med, Stuttgart, Germany
来源
ZEITSCHRIFT FUR RHEUMATOLOGIE | 2012年 / 71卷 / 08期
关键词
HLA-B51; Pseudofolliculitis; Erythema nodosum; Oligoarthritis; Occlusive retinal vasculitis; GENOME-WIDE ASSOCIATION; OF-THE-LITERATURE; BEHCETS-DISEASE; INTERFERON-ALPHA; ARTHRITIS; IL23R-IL12RB2; MOUTH; IL10;
D O I
10.1007/s00393-012-1012-x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Beh double dagger et's disease is a systemic disorder with the histopathological correlate of leukocytoclastic vasculitis. Pathogenetically, besides a strong genetic component participation of the innate immune system and an autoinflammatory component are discussed. The disease is most common in countries along the former silk route but in Germany the disease is rare (prevalence approximately 0.6/100,000). Oral aphthous ulcers are the main symptom, followed by skin manifestations, genital ulcers and oligoarthritis of large joints. Severe manifestations, threatening quality of life and even life itself, are the gastrointestinal manifestations which often perforate, arterial, mainly pulmonary arterial aneurysms which cause life-threatening bleeding, CNS manifestations and ocular disease, which with occlusive retinal vasculitis often leads to blindness. For milder manifestations low-dose steroids and colchicine are used, for moderate manifestations such as arthritis or ocular disease not immediately threatening visual acuity, azathioprin or cyclosporin A are combined with steroids. For severe manifestations, interferon-alpha, TNF-antagonists or cytotoxic drugs are recommended. Interleukin 1 (IL-1) antagonists are currently being examined in clinical studies.
引用
收藏
页码:685 / 696
页数:12
相关论文
共 26 条
[1]  
Adamantiades B., 1930, ARCHIA IATRIKIS ETAI, P586
[2]   Epidemiological features and visual prognosis of Behcet's disease [J].
Ando, K ;
Fujino, Y ;
Hijikata, K ;
Izawa, Y ;
Masuda, K .
JAPANESE JOURNAL OF OPHTHALMOLOGY, 1999, 43 (04) :312-317
[3]  
[Anonymous], LANCET
[4]   Anti-TNF Agents for Behcet's Disease: Analysis of Published Data on 369 Patients [J].
Arida, Aikaterini ;
Fragiadaki, Kalliopi ;
Giavri, Eirini ;
Sfikakis, Petros P. .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2011, 41 (01) :61-70
[5]  
Behçet H, 1937, DERMATOL WOCHENSCHR, V105, P1152
[6]   Behcet's disease:: Ocular effects and treatment [J].
Deuter, Christoph M. E. ;
Koetter, Ina ;
Wallace, Graham R. ;
Murray, Philip I. ;
Stuebiger, Nicole ;
Zierhut, Manfred .
PROGRESS IN RETINAL AND EYE RESEARCH, 2008, 27 (01) :111-136
[7]   Long-Term Remission After Cessation of Interferon-α Treatment in Patients With Severe Uveitis Due to Behcet's Disease [J].
Deuter, Christoph M. E. ;
Zierhut, Manfred ;
Moehle, Antje ;
Vonthein, Reinhard ;
Stuebiger, Nicole ;
Koetter, Ina .
ARTHRITIS AND RHEUMATISM, 2010, 62 (09) :2796-2805
[8]  
Dilsen N, 1985, RECENT ADV BEHCETS D, pS 177
[9]   Autoimmunity vs autoinflammation in Behcet's disease:: do we oversimplify a complex disorder? [J].
Direskeneli, H. .
RHEUMATOLOGY, 2006, 45 (12) :1461-1465
[10]   Pulmonary artery aneurysms in Behcet syndrome [J].
Hamuryudan, V ;
Er, T ;
Seyahi, E ;
Akman, C ;
Tüzün, H ;
Fresko, I ;
Yurdakul, S ;
Numan, R ;
Yazici, H .
AMERICAN JOURNAL OF MEDICINE, 2004, 117 (11) :867-870